Product information and disease descriptionProduct descriptionProduct informationPharmacology
Mechanism of action
4 evidence topics · 4 sources
Mechanism of action: prescribing information
Mechanism of action: manufacturer description at approval
Restoration of cholesterol trafficking in the central nervous system: company nonclinical studies
Cyclodextrins as lipid-mobilizing agents
“Recently, uncomplexed cyclodextrins have emerged as potent therapeutic compounds in their own right, based on their ability to sequester and mobilize cellular lipids.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In particular, 2-hydroxypropyl-β-cyclodextrin (HPβCD) has garnered attention because of its cholesterol chelating properties, which appear to treat a rare neurodegenerative disorder and to promote atherosclerosis regression related to stroke and heart disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote